Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis

Yukie Hayashi; Naoki Hosoe; Kaoru Takabayashi; Kenji J.L. Limpias Kamiya; Kai Tsugaru; Keitaro Shimozaki; Kenro Hirata; Kayoko Fukuhara; Seiichiro Fukuhara; Makoto Mutaguchi; Tomohisa Sujino; Yasutaka Sukawa; Yasuo Hamamoto; Makoto Naganuma; Hiromasa Takaishi; Masayuki Shimoda; Haruhiko Ogata; Takanori Kanai

doi:10.1007/s10620-020-06441-w

Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis

Yukie Hayashi, Naoki Hosoe, Kaoru Takabayashi, Kenji J.L. Limpias Kamiya, Kai Tsugaru, Keitaro Shimozaki, Kenro Hirata, Kayoko Fukuhara, Seiichiro Fukuhara, Makoto Mutaguchi, Tomohisa Sujino, Yasutaka Sukawa, Yasuo Hamamoto, Makoto Naganuma, Hiromasa Takaishi, Masayuki Shimoda, Haruhiko Ogata, Takanori Kanai

研究成果: Article › 査読

15 被引用数 (Scopus)

本文言語	English
ページ（範囲）	2129-2134
ページ数	6
ジャーナル	Digestive Diseases and Sciences
巻	66
号	6
DOI	https://doi.org/10.1007/s10620-020-06441-w
出版ステータス	Published - 2021 6月

ASJC Scopus subject areas

生理学
消化器病学

文献へのアクセス

10.1007/s10620-020-06441-w

他のファイルとリンク

引用スタイル

Hayashi, Y., Hosoe, N., Takabayashi, K., Limpias Kamiya, K. J. L., Tsugaru, K., Shimozaki, K., Hirata, K., Fukuhara, K., Fukuhara, S., Mutaguchi, M., Sujino, T., Sukawa, Y., Hamamoto, Y., Naganuma, M., Takaishi, H., Shimoda, M., Ogata, H., & Kanai, T. (2021). Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis. Digestive Diseases and Sciences, 66(6), 2129-2134. https://doi.org/10.1007/s10620-020-06441-w

Hayashi, Y , Hosoe, N , Takabayashi, K, Limpias Kamiya, KJL, Tsugaru, K, Shimozaki, K, Hirata, K, Fukuhara, K, Fukuhara, S, Mutaguchi, M, Sujino, T, Sukawa, Y, Hamamoto, Y, Naganuma, M, Takaishi, H, Shimoda, M, Ogata, H & Kanai, T 2021, 'Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis', Digestive Diseases and Sciences, vol. 66, no. 6, pp. 2129-2134. https://doi.org/10.1007/s10620-020-06441-w

@article{d9aa1477959e4137b10b3a5aa164bdbd,

title = "Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis",

keywords = "Colitis, Enteritis, Gastritis, Immune check point inhibitor, Immune-rerated adverse events (irAE)",

author = "Yukie Hayashi and Naoki Hosoe and Kaoru Takabayashi and {Limpias Kamiya}, {Kenji J.L.} and Kai Tsugaru and Keitaro Shimozaki and Kenro Hirata and Kayoko Fukuhara and Seiichiro Fukuhara and Makoto Mutaguchi and Tomohisa Sujino and Yasutaka Sukawa and Yasuo Hamamoto and Makoto Naganuma and Hiromasa Takaishi and Masayuki Shimoda and Haruhiko Ogata and Takanori Kanai",

year = "2021",

month = jun,

doi = "10.1007/s10620-020-06441-w",

language = "English",

volume = "66",

pages = "2129--2134",

journal = "Digestive Diseases and Sciences",

issn = "0163-2116",

publisher = "Springer New York",

number = "6",

}

TY - JOUR

T1 - Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis

AU - Hayashi, Yukie

AU - Hosoe, Naoki

AU - Takabayashi, Kaoru

AU - Limpias Kamiya, Kenji J.L.

AU - Tsugaru, Kai

AU - Shimozaki, Keitaro

AU - Hirata, Kenro

AU - Fukuhara, Kayoko

AU - Fukuhara, Seiichiro

AU - Mutaguchi, Makoto

AU - Sujino, Tomohisa

AU - Sukawa, Yasutaka

AU - Hamamoto, Yasuo

AU - Naganuma, Makoto

AU - Takaishi, Hiromasa

AU - Shimoda, Masayuki

AU - Ogata, Haruhiko

AU - Kanai, Takanori

PY - 2021/6

Y1 - 2021/6

KW - Colitis

KW - Enteritis

KW - Gastritis

KW - Immune check point inhibitor

KW - Immune-rerated adverse events (irAE)

UR - http://www.scopus.com/inward/record.url?scp=85087406917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087406917&partnerID=8YFLogxK

U2 - 10.1007/s10620-020-06441-w

DO - 10.1007/s10620-020-06441-w

M3 - Article

C2 - 32621258

AN - SCOPUS:85087406917

SN - 0163-2116

VL - 66

SP - 2129

EP - 2134

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

IS - 6

ER -